Skip to main content
Signal8
RIGGS RORY B profile photo

Rory B. Riggs

CIK: 0001016835

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (6.7%)

Derivative conversions

Awards (A)9 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Cibus, Inc. logo
CBUS

Cibus, Inc.

Director
Intra-Cellular Therapies, Inc. logo
ITCI

Intra-Cellular Therapies, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jun 2, 2026
    Award(A)

    Stock Option (Right-to-Buy)

    Direct
    77.6K shares-
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jan 29, 2026
    Award(A)
    Direct
    333.3K shares at avg. $1.50$500K
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jun 9, 2025
    In-the-Money(X)
    Direct
    50K shares at avg. $0.01$500
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jun 9, 2025
    In-the-Money(X)
    Direct
    4M shares at avg. $0.00$400
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jun 5, 2025
    Award(A)
    Direct
    5.7M shares at avg. $1.75$10.0M
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    May 22, 2025
    Award(A)

    Stock Option (Right-to-Buy)

    Direct
    39.3K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Disposition(D)
    Direct
    131.5K shares at avg. $132.00$17.4M
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jan 21, 2025
    Award(A)

    Pre-Funded Warrant

    Direct
    4M shares at avg. $2.50-
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Jan 21, 2025
    Award(A)

    Common Warrant

    Direct
    4M shares-
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Dec 31, 2024
    Conversion(C)
    Direct
    1.4M shares-
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Dec 31, 2024
    Conversion(C)
    Direct
    1.4M shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Dec 31, 2024
    Award(A)
    Direct
    215 shares at avg. $83.52$18K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Sep 30, 2024
    Award(A)
    Direct
    246 shares at avg. $73.17$18K
  • Cibus, Inc. logo
    CBUS

    Cibus, Inc.

    Sep 18, 2024
    Award(A)
    Direct
    250K shares at avg. $4.00$1.0M
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Jun 18, 2019
    Exercise(M)
    Direct
    14.2K shares-

1-15 of 15

About RIGGS RORY B

RIGGS RORY B (SEC CIK 0001016835) files insider reports with the SEC as Director of Cibus, Inc. (CBUS) and Director of Intra-Cellular Therapies, Inc. (ITCI).

Signal8 holds 12 ownership filings by RIGGS RORY B, all Form 4s, filed between Sep 20, 2024 and Jun 4, 2026. Those filings report 15 transactions, from Jun 18, 2019 to Jun 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on RIGGS RORY B's filings is in SAN DIEGO, CA.

Recent filings by RIGGS RORY B

  • Jun 2, 2026: Grant or award of CBUS derivative securities (Form 4, code A).
  • Jan 29, 2026: Grant or award of CBUS shares (Form 4, code A).
  • Jun 9, 2025: Option exercises of CBUS shares (2 lines, Form 4, code X).
  • Jun 5, 2025: Grant or award of CBUS shares (Form 4, code A).
  • May 22, 2025: Grant or award of CBUS derivative securities (Form 4, code A).

Other insiders filing for Cibus, Inc. (CBUS)

How to read Form 4 transaction codes